|
1
|
Zhu F, Dai C, Fu Y, Loo JF, Xia D, Gao SP,
Ma Z and Chen Z: Physalin A exerts antitumor activity in non-small
cell lung cancer cell lines by suppressing JAK/STAT3 signaling.
Oncotarget. 7:9462–9476. 2016.PubMed/NCBI
|
|
2
|
Kubo H, Suzuki T, Matsushima T, Ishihara
H, Uchino K, Suzuki S, Tada S, Yoshimura M and Kondo T:
Cyclin-dependent kinase-specific activity predicts the prognosis of
stage I and stage II non-small cell lung cancer. Bmc Cancer.
14:7552014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cromie MM and Gao W:
Epigallocatechin-3-gallate enhances the therapeutic effects of
leptomycin B on human lung cancer a549 cells. Oxid Med Cell Longev
2015. 2173042015.
|
|
4
|
Zheng XJ, Yang ZX, Dong YJ, Zhang GY, Sun
MF, An XK, Pan LH and Zhang SL: Downregulation of leptin inhibits
growth and induces apoptosis of lung cancer cells via the Notch and
JAK/STAT3 signaling pathways. Biol Open. 5:794–800. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Carbone DP, Gandara DR, Antonia SJ,
Zielinski C and Paz-Ares L: Non-small-cell lung cancer: Role of the
immune system and potential for immunotherapy. J Thorac Oncol.
10:974–984. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chang YJ, Hsu SL, Liu YT, Lin YH, Lin MH,
Huang SJ, Ho JA and Wu LC: Gallic acid induces necroptosis via
TNF-α signaling pathway in activated hepatic stellate cells. PLoS
One. 10:e1207132015.
|
|
7
|
Wang R, Ma L, Weng D, Yao J, Liu X and Jin
F: Gallic acid induces apoptosis and enhances the anticancer
effects of cisplatin in human small cell lung cancer H446 cell line
via the ROS-dependent mitochondrial apoptotic pathway. Oncol Rep.
35:3075–3083. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kaur M, Velmurugan B, Rajamanickam S,
Agarwal R and Agarwal C: Gallic acid, an active constituent of
grape seed extract, exhibits anti-proliferative, pro-apoptotic and
antitumorigenic effects against prostate carcinoma xenograft growth
in nude mice. Pharm Res. 26:2133–2140. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
He Z, Chen AY, Rojanasakul Y, Rankin GO
and Chen YC: Gallic acid, a phenolic compound, exerts
anti-angiogenic effects via the PTEN/AKT/HIF-1alpha/VEGF signaling
pathway in ovarian cancer cells. Oncol Rep. 35:291–297. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee JH, Kim C, Baek SH, Ko JH, Lee SG,
Yang WM, Um JY, Sethi G and Ahn KS: Capsazepine inhibits JAK/STAT3
signaling, tumor growth, and cell survival in prostate cancer.
Oncotarget. 8:17700–17711. 2017.PubMed/NCBI
|
|
11
|
Wen W, Liang W, Wu J, Kowolik CM, Buettner
R, Scuto A, Hsieh MY, Hong H, Brown CE, Forman SJ, et al: Targeting
JAK1/STAT3 signaling suppresses tumor progression and metastasis in
a peritoneal model of human ovarian cancer. Mol Cancer Ther.
13:3037–3048. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhou F, Cheng L, Qiu LX, Wang MY, Li J,
Sun MH, Yang YJ, Wang JC, Jin L, Wang YN and Wei QY: Associations
of potentially functional variants in IL-6, JAKs, STAT3 with
gastric cancer risk in an eastern Chinese population. Oncotarget.
7:28112–28123. 2016.PubMed/NCBI
|
|
13
|
Gritsina G, Xiao F, O'Brien SW, Gabbasov
R, Maglaty MA, Xu RH, Thapa RJ, Zhou Y, Nicolas E, Litwin S, et al:
Targeted blockade of JAK/STAT3 signaling inhibits ovarian carcinoma
growth. Mol Cancer Ther. 14:1035–1047. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang CL, Liu YY, Ma YG, Xue YX, Liu DG,
Ren Y, Liu XB, Li Y and Li Z: Curcumin blocks small cell lung
cancer cells migration, invasion, angiogenesis, cell cycle and
neoplasia through Janus kinase-STAT3 signalling pathway. PLoS One.
7:e379602012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2ΔΔCT method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee CY, Sher HF, Chen HW, Liu CC, Chen CH,
Lin CS, Yang PC, Tsay HS and Chen JJ: Anticancer effects of
tanshinone I in human non-small cell lung cancer. Mol Cancer Ther.
7:3527–3538. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yu J, Xiao J, Yang Y and Cao B:
Oxaliplatin-based doublets versus cisplatin or carboplatin-based
doublets in the first-line treatment of advanced nonsmall cell lung
cancer. Medicine. 94:e10722015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Qian HR, Shi ZQ, Zhu HP, Gu LH, Wang XF
and Yang Y: Interplay between apoptosis and autophagy in colorectal
cancer. Oncotarget. 8:62759–62768. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu G, Pei F, Yang F, Li L, Amin AD, Liu
S, Buchan JR and Cho WC: Role of autophagy and apoptosis in
non-small-cell lung cancer. Int J Mol Sci. 18(pii): E3672017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jin G, Zhao J, Yang YI, Liu K, Jiang Y,
Zhang X, Zhang Y, Huang Y, Lu J and Dong Z: JAK/STAT3 signaling
pathway mediates endothelial-like differentiation of immature
dendritic cells. Oncol Lett. 10:3471–3477. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fang J, Lau V, Wu PC, Lai CL and Lau J:
Imbalance between cell proliferation and programmed cell dealth
*apoptosis* in hepatocellular carcinoma. Gastroenterology. 108 (4
Suppl 3):A10631995. View Article : Google Scholar
|
|
22
|
Wei W, Wu J, Liu L, Tian Y, Buettner R,
Hsieh MY, Horne H, Dellinger TH, Han ES, Jove R, et al: Synergistic
antitumor effect of combined inhibition of EGFR and JAK/STAT3
pathways in human ovarian cancer. Mol Cancer. 14:1002015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tang SN, Fu J, Shankar S and Srivastava
RK: EGCG enhances the therapeutic potential of gemcitabine and
CP690550 by inhibiting STAT3 signaling pathway in human pancreatic
cancer. PLoS One. 7:e310672012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wen W, Wu J, Liu L, Tian Y, Buettner R,
Hsieh MY, Horne D, Dellinger TH, Han ES, Jove R, et al: Synergistic
anti-tumor effect of combined inhibition of EGFR and JAK/STAT3
pathways in human ovarian cancer. Mol Cancer. 14:1002015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li S, Priceman SJ, Xin H, Zhang W, Deng J,
Liu Y, Huang J, Zhu W, Chen M, Hu W, et al: Icaritin inhibits
JAK/STAT3 signaling and growth of renal cell carcinoma. PLoS One.
8:e816572013. View Article : Google Scholar : PubMed/NCBI
|
